temozolomide has been researched along with sc002 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goze, C; Pujol, CN; Pujol, JL; Roch, B | 1 |
| Nazha, B; Owonikoko, TK | 1 |
1 review(s) available for temozolomide and sc002
| Article | Year |
|---|---|
[Medical treatment of small cell lung cancer: Can we leave the area of cisplatin-etoposide?]
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Aurora Kinase A; Benzodiazepinones; Dacarbazine; DNA Damage; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Enhancer of Zeste Homolog 2 Protein; Humans; Immunoconjugates; Lung Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Protein Serine-Threonine Kinases; Receptors, Notch; Small Cell Lung Carcinoma; Temozolomide; Tumor Suppressor Proteins | 2018 |
1 other study(ies) available for temozolomide and sc002
| Article | Year |
|---|---|
The clinical conundrum of managing relapsed small cell lung cancer.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Clinical Decision-Making; Disease Progression; Etoposide; Humans; Immunoconjugates; Irinotecan; Liver Neoplasms; Lung Neoplasms; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Piperazines; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Temozolomide; Thiourea; Topotecan | 2019 |